BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, January 3, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Financings for Oct. 15, 2020

Oct. 15, 2020
Med-tech firms raising money in public or private financings, including: Chronometriq, Osmind, Si-Bone, Veritas Intercontinental.
Read More

Appointments and advancements for Oct. 15, 2020

Oct. 15, 2020
New hires and promotions in the med-tech industry, including: Hanger, Mdlive, Myriad, Nuvasive, Sanara, Zava.
Read More

Regulatory actions for Oct. 15, 2020

Oct. 15, 2020
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Apexigen, Armata, Eton, Merck, Immunitybio, OS, Regeneron, Zhittya.
Read More

Other news to note for Oct. 15, 2020

Oct. 15, 2020

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Allogene, Amag, Antlia, Apellis, Astellas, Covis, Entos, FS, Gemini, Insilico, Iota, Mallinckrodt, Meabco, Mirum, Oncopep, Mana, National Comprehensive Cancer Network, Puma, Sanofi, Science 37, Surrozen, Taisho, Tenax, Titan, Tonix, Translate, XL-protein.


Read More

In the clinic for Oct. 15, 2020

Oct. 15, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Anavex, Apellis, Astex, Castle Creek, Eiger, GNT, Ionis, J&J, Janssen, Kalvista, Lysogene, Oryzon, Otsuka, Regenrx, Regulus, Sage, Vertex.
Read More

Financings for Oct. 15, 2020

Oct. 15, 2020
Biopharmas raising money in public or private financings, including: Artelo, Azitra , Bayer, Evofem, Kronos, Poxel, Praxis, Sensorion, Spruce, Vectivbio.
Read More

Appointments and advancements for Oct. 15, 2020

Oct. 15, 2020
New hires and promotions in the biopharma industry, including: Effector, Ibio, Immunocore, Janssen.
Read More

Appointments and advancements for Oct. 14, 2020

Oct. 14, 2020
New hires and promotions in the med-tech industry, including: Medicx, Quest Analytics.
Read More

Regulatory actions for Oct. 14, 2020

Oct. 14, 2020
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aferetica, Cytosorbents, New World Medical.
Read More

In the clinic for Oct. 14, 2020

Oct. 14, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abiomed, Cardiovascular Systems, Nuvera Medical, Podimetrics.
Read More
Previous 1 2 … 1436 1437 1438 1439 1440 1441 1442 1443 1444 … 1728 1729 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 31, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 2, 2026.
  • Sickle cell illustration

    AND-017 increases RBC and hemoglobin in sickle cell disease

    BioWorld Science
    Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
  • Businessman, businesswoman handshake

    Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact

    BioWorld
    Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
  • Asia focused map inside light bulb

    Big pharma taps fast Asia innovation in search of next Keytruda

    BioWorld
    Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing